Literature DB >> 19705089

Cyp46 polymorphisms in Alzheimer's disease: a review.

Anália Nusya Medeiros Garcia1, Maria Tereza Cartaxo Muniz, Hugo Rafael Souza e Silva, Helker Albuquerque da Silva, Luiz Athayde-Junior.   

Abstract

Increasing research findings argue for a link between brain cholesterol turnover and Alzheimer's disease (AD). High cerebral levels of this lipid increase Ass load. The elimination of cerebral cholesterol involves two mechanisms, dependent of apolipoprotein E and cholesterol 24-hydroxylase (CYP46). CYP46 is a gene associated with AD; the most studied single nucleotide polymorphism is the rs754203, which changes T-->C. Some studies describe that this polymorphism is possibly associated with loss of function of CYP46; others describe that it is possibly associated with cerebral cholesterol accumulation or an increase of CYP46 activity leading to an accumulation of the 24S-hydroxycholesterol in cerebrospinal fluid. Publications about this subject around the world are controversial. Some studies associate the T allele with AD and others the C allele. The aim of this review is to describe and summarize the findings of the researches about the relationship between CYP46 and AD that have been published in the past 9 years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705089     DOI: 10.1007/s12031-009-9227-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  34 in total

Review 1.  Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease.

Authors:  Benjamin Wolozin
Journal:  Arch Neurol       Date:  2003-01

2.  Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.

Authors:  Amro Kabbara; Nathalie Payet; Dominique Cottel; Bernard Frigard; Philippe Amouyel; Jean-Charles Lambert
Journal:  Neurosci Lett       Date:  2004-06-10       Impact factor: 3.046

Review 3.  Genetic association of CYP46 and risk for Alzheimer's disease.

Authors:  Onofre Combarros; Jon Infante; Javier Llorca; José Berciano
Journal:  Dement Geriatr Cogn Disord       Date:  2004-07-29       Impact factor: 2.959

4.  Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients.

Authors:  Y Li; L W Chu; Y Q Chen; B M Y Cheung; R Y H Leung; P Y Yik; K M Ng; W Mak; D Y Jin; P St George-Hyslop; Y Q Song
Journal:  Dement Geriatr Cogn Disord       Date:  2006-09-08       Impact factor: 2.959

5.  Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.

Authors:  S Helisalmi; S Vepsäläinen; A M Koivisto; A Mannermaa; S Iivonen; M Hiltunen; V Kiviniemi; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

6.  24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.

Authors:  A Papassotiropoulos; D Lütjohann; M Bagli; S Locatelli; F Jessen; R Buschfort; U Ptok; I Björkhem; K von Bergmann; R Heun
Journal:  J Psychiatr Res       Date:  2002 Jan-Feb       Impact factor: 4.791

Review 7.  The role of 24S-hydroxycholesterol in Alzheimer's disease.

Authors:  H Kölsch; D Lütjohann; K von Bergmann; R Heun
Journal:  J Nutr Health Aging       Date:  2003       Impact factor: 4.075

Review 8.  Genetic susceptibility factors for Alzheimer's disease.

Authors:  F Richard; P Amouyel
Journal:  Eur J Pharmacol       Date:  2001-01-19       Impact factor: 4.432

9.  Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.

Authors:  Heike Kölsch; D Lütjohann; M Ludwig; A Schulte; U Ptok; F Jessen; K von Bergmann; M L Rao; W Maier; R Heun
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.

Authors:  Ewa Golanska; Krystyna Hulas-Bigoszewska; Monika Sieruta; Izabela Zawlik; Monika Witusik; Sylwia M Gresner; Tomasz Sobow; Maria Styczynska; Beata Peplonska; Maria Barcikowska; Pawel P Liberski; Elizabeth H Corder
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more
  17 in total

Review 1.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

Review 2.  24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.

Authors:  Min-Yu Sun; Andrew J Linsenbardt; Christine M Emnett; Lawrence N Eisenman; Yukitoshi Izumi; Charles F Zorumski; Steve Mennerick
Journal:  Neuroscientist       Date:  2015-01-27       Impact factor: 7.519

3.  CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.

Authors:  Ling Li; Fan Zeng; Yu-Hui Liu; Hui-Yun Li; Shu-Yang Dong; Ze-Yan Peng; Yan-Jiang Wang; Hua-Dong Zhou
Journal:  Mol Neurobiol       Date:  2018-03-07       Impact factor: 5.590

4.  PRND 3'UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease.

Authors:  Marcin Flirski; Monika Sieruta; Ewa Golańska; Iwona Kłoszewska; Paweł P Liberski; Tomasz Sobów
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

Review 5.  Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

Authors:  Charmaine S Ferguson; Rachel F Tyndale
Journal:  Trends Pharmacol Sci       Date:  2011-10-03       Impact factor: 14.819

Review 6.  Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?

Authors:  Andrew J Beel; Masayoshi Sakakura; Paul J Barrett; Charles R Sanders
Journal:  Biochim Biophys Acta       Date:  2010-03-18

7.  Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.

Authors:  Alana C Costa; Helena P G Joaquim; Valéria S Nunes; Daniel S Kerr; Guilherme S Ferreira; Orestes V Forlenza; Wagner F Gattaz; Leda Leme Talib
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-31       Impact factor: 5.270

Review 8.  Brain cholesterol metabolism, oxysterols, and dementia.

Authors:  Timothy M Hughes; Caterina Rosano; Rhobert W Evans; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma.

Authors:  Georg Mossböck; Martin Weger; Christoph Faschinger; Otto Schmut; Wilfried Renner; Andreas Wedrich; Christina Zimmermann; Yosuf El-Shabrawi
Journal:  Mol Vis       Date:  2011-02-26       Impact factor: 2.367

10.  Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk.

Authors:  Miguel Moutinho; Maria João Nunes; Jorge C Correia; Maria João Gama; Margarida Castro-Caldas; Angel Cedazo-Minguez; Cecília M P Rodrigues; Ingemar Björkhem; Jorge L Ruas; Elsa Rodrigues
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.